List view / Grid view

News

€196 million Pan-European drug discovery platform launched

7 February 2013 | By Innovative Medicines Initiative (IMI)

Large pharmaceutical companies join forces with small and medium-sized enterprises (SMEs) and academia in an IMI-supported public private partnership (PPP) to enhance early drug discovery and so address the ever-increasing need for innovative therapeutics to tackle unmet medical needs...

Amgen Outlines Long-Term Strategy

7 February 2013 | By Amgen

Amgen outlined the company's long-term strategy during a Business Review meeting with analysts and investors in New York City...

European Commission approves HUMIRA’s label update

5 February 2013 | By

AbbVie has announced the European Commission (EC) has approved an update to the label for HUMIRA® (adalimumab) for the treatment of adults with moderate to severe rheumatoid arthritis (RA). The update adds data demonstrating the long-term clinical benefit of HUMIRA, making it the first and only biologic medication available with…